Liver Function Tests

References

• Gray C. H. Bile pigments. Health and Disease. Charles C Thomas, Springfield, Ill 1961
   Google Scholar
• Klatskin G. Bile pigment metabolism. Ann. Rev. Med. 1961; 12: 211
   PubMed Web of Science ®Google Scholar
• Lester R., Schmid R. Bilirubin metabolism. New Eng. J. Med. 1964; 270: 779
   PubMedGoogle Scholar
• Zieve L., Hill E., Hanson M., Falcone A. B., Watson C. J. Normal and abnormal variations and clinical significance of the one-minute and total serum bilirubin determinations. J. Lab. Clin. Med. 1951; 38: 446
   PubMed Web of Science ®Google Scholar
• Thompson H. E., Wyatt B. L. Experimentally induced jaundice (hyperbilirubinemia): report of animal experimentation and of physiologic effect of jaundice in patients with atrophic arthritis. Arch. Intern Med. 1938; 61: 481
   Google Scholar
• Hoffbauer F. W., Rames E. D., Meinert J. K. Limitations and merits of a single serum sample analysis in differential diagnosis of jaundice. J. Lab. Clin Med. 1949; 34: 1259
   PubMedGoogle Scholar
• Gambino S. R., Otter A., Burns W. Direct serum bilirubin and sulfobromophthalein test in occult liver disease. J.A.M.A. 1967; 201: 1047
   PubMedGoogle Scholar
• Schaefer J., Schiff L. Liver function tests in metastatic tumor of the liver: study of 100 cases. Gastroenterology 1965; 49: 360
   PubMedGoogle Scholar
• Combes B., Schenker S. Diseases of the Liver, 3rd ed., L. Schiff. J. B. Lippincott Co., Philadelphia 1969
   Google Scholar
• Hardison W. G., Lee F. I. Prognosis in acute liver disease of the alcoholic patient. New Eng. J. Med. 1966; 275: 61
   PubMed Web of Science ®Google Scholar
• Ritt D. J., Whelan G., Werner D. J., Eigenbrodt E. H., Schenker S., Combes B. Acute hepatic necrosis with stupor or coma: An analysis of 31 patients. Medicine 1969; 48: 151
   PubMed Web of Science ®Google Scholar
• Fulop M., Sandson J., Brazeau P. Dialysability, protein binding and renal excretion of plasma conjugated bilirubin. J. Clin. Invest. 1965; 44: 666
   PubMed Web of Science ®Google Scholar
• Klatskin G., Bungards L. An improved test for bilirubin in urine. New Eng. J. Med. 1953; 248: 712
   PubMedGoogle Scholar
• Gellis S. S., Stokes J. The methylene blue test in infectious (epidemic) hepatitis. J.A.M.A. 1945; 128: 782
   Google Scholar
• Neefe J. R., Reinhold J. G. Laboratory aids in diagnosis and management of infectious (epidemic) hepatitis. Analysis of results obtained on 34 volunteers during the early and convalescent stages of induced hepatitis. Gastroenterology 1964; 7: 393
   Google Scholar
• Tisdale W. A., Klatskin G., Kinsella E. D. The significance of the direct-reading fraction of serum bilirubin in hemolytic jaundice. Amer. J. Med. 1959; 26: 214
   PubMed Web of Science ®Google Scholar
• Steigmann F., Dyniewicz J. M. Studies of urobilinogen. I. The daily urobilinogen excretion in urine and feces in health and disease: an evaluation of Watson's and Sparkman's methods. Gastroenterology 1943; 1: 743
   Google Scholar
• Zieve L., Hill E. An evaluation of factors influencing the discriminative effectiveness of a group of liver function tests. II. Normal limits of 11 representative hepatic tests. Gastroenterology 1955; 28: 766
   PubMed Web of Science ®Google Scholar
• Bourke E., Milne M. D., Stokes G. S. Mechanisms of renal excretion of urobilinogen. Brit Med. J. 1965; 2: 1510
   PubMedGoogle Scholar
• Watson C. J. Regurgitation jaundice: clinical differentiation of the common forms, with particular reference to the degree of biliary obstruction. J.A.M.A. 1940; 114: 2427
   Google Scholar
• Wollaeger E. E., Gross J. B. Complete obstruction of the extrahepatic biliary tract due to carcinoma as determined by the fecal urobilinogen test: incidence and effect on serum bilirubin concentrations. Medicine 1966; 45: 529
   PubMedGoogle Scholar
• Watson G. J., Hawkinson V. Studies on urobilinogen. VI. Further experience with the simple quantitative Ehrlich reaction. Corrected calibration of Evelyn colorimeter with a pontacyl dye mixture in terms of urobilinogen. Amer. J. Clin. Path. 1947; 17: 108
   PubMedGoogle Scholar
• Combes B. Excretory function of the liver. The Liver, C. Rouiller. Academic Press, New York 1964; Vol. 2, Chap. 12
   Google Scholar
• Mateer J. G., Baltz J. I., Marion D. F., MacMillan J. M. Liver function tests. J.A.M.A. 1943; 121: 723
   Google Scholar
• Breen K. J., Levinson J. D., Terman J., Schenker S. Standard BSP test: Importance of sampling site. Lancet 1971; 1: 341
   PubMedGoogle Scholar
• Fleck A., Morrison B. A. The determination of bromsulphthalein in serum. Clin. Chim. Acta 1970; 30: 751
   PubMedGoogle Scholar
• Freston J. W., Englert E. The influence of age and excessive body weight on the distribution and metabolism of bromsulphalein. Clin. Sci. 1967; 33: 301
   PubMed Web of Science ®Google Scholar
• Thompson E. N., Williams R. Effect of age on liver function with particular reference to the bromsulphalein excretion. Gut 1965; 6: 266
   PubMed Web of Science ®Google Scholar
• Schoenfield L. J., Faulk W. T. Studies of sulfobromphthalein sodium (BSP) metabolism in man. II. The effect of artificially induced fever, norethandrolone (Nilevar) and Iopanoic Acid (Telepaque). J. Clin. Invest. 1964; 43: 1419
   PubMedGoogle Scholar
• Drenick E. J. The relation of BSP retention during prolonged fasts to changes in plasma volume. Metabolism 1968; 17: 522
   PubMedGoogle Scholar
• Combes B., Shibata H., Adams R., Mitchell B. D., Trammell V. Alterations in sulfobromophthalein sodium removal mechanisms from blood during normal pregnancy. J. Clin. Invest. 1963; 42: 1431
   PubMed Web of Science ®Google Scholar
• Meyer R. R. Effect of iopanoic acid on the sulfobromphthalein test. J.A.M.A. 1964; 194: 343
   Google Scholar
• Grausz H., Schmid R. Relation between plasma albumin level and hepatic BSP removal. New Eng. J. Med. 1971; 284: 1403
   PubMed Web of Science ®Google Scholar
• Zieve L., Hill E. An evaluation of factors influencing the discriminative effectiveness of a group of liver function tests. III. Relative effectiveness of hepatic tests in cirrhosis. Gastroenterology 1955; 28: 785
   PubMed Web of Science ®Google Scholar
• Shani M., Selighson U., Gilon E., Sheba C., Adam A. Dubin-Johnson syndrome in Israel. I. Clinical, laboratory and genetic aspects of 101 cases. Quart. J. Med. 1970; 39: 549
   PubMedGoogle Scholar
• Dollinger M. R., Brandborg L. L. Late elevation in serum bromsulfalein in Dubin-Johnson syndrome. Amer. J. Dig. Dis. 1967; 12: 413
   PubMedGoogle Scholar
• Mandema E., de Fraiture W. H., Nieweg H. O., Arends A. Familial chronic idiopathic jaundice (Dubin-Spring disease), with a note on bromsulphalein metabolism in this disease. Amer. J. Med. 1960; 28: 42
   PubMedGoogle Scholar
• Iber F. L. Reactions to sulfobromophthalein sodium injection, USP. Bull. Johns Hopkins Hosp. 1965; 116: 132
   PubMedGoogle Scholar
• Juhl E., Hilden M. and Dauv-Pederson, Atypical reactions to bromsulphthalein (BSP). Lancet 1970; 2: 424
   PubMedGoogle Scholar
• Wheeler H. O., Meltzer J. I., Bradley S. E. Biliary transport and hepatic storage of sulfobromophthalein sodium in unanesthetized dog, in normal man and in patients with hepatic disease. J. Clin. Invest. 1960; 39: 1131
   PubMed Web of Science ®Google Scholar
• Barber-Riley G., Goetzee A. E., Richards T. G., Thompson J. Y. The transfer of bromsulphthalein from the plasma to bile in man. Clin. Sci. 1961; 20: 149
   PubMedGoogle Scholar
• Posen S., Cornish C. J., Horne M., Saini P. Placental alkaline phosphatase and pregnancy. Ann N. Y. Acad. Sci 1969; 166: 733
   PubMed Web of Science ®Google Scholar
• Posen S. Alkaline phosphatase. Ann Intern. Med. 1967; 67: 183
   PubMed Web of Science ®Google Scholar
• Deren J. J., Williams L A., Muench H., Chalmers T., Zamchek N. Comparative study of four methods of determining alkaline phosphatase. New Eng. J. Med. 1964; 270: 1277
   PubMedGoogle Scholar
• Tietz N. W., Woodrow D., Woodrow B. A comparative study of the Bodansky and the Bessey, Lowry and Brock methods for alkaline phosphatase in serum. Clin. Chim. Acta 1965; 15: 365
   Google Scholar
• Kaplan M. M., Righetti A. Induction of rat liver alkaline phosphatase: The mechanism of the serum elevation in bile duct obstruction. J. Clin. Invest. 1970; 49: 508
   PubMedGoogle Scholar
• Posen S., Neale F. C., Clubb J. S. Heat inactivation in the study of human alkaline phosphatase. Ann. Intern. Med. 1965; 62: 1234
   PubMed Web of Science ®Google Scholar
• Hill P. G., Sammons H. G. An interpretation of the elevation of serum alkaline phosphatase in disease. J. Clin. Path. 1967; 20: 654
   PubMed Web of Science ®Google Scholar
• Kowlessar O. D., Haeffner L. J., Riley R. M., Sleisenger M. H. Comparative study of serum leucine aminopeptidase, 5-nucleotidase and nonspecific alkaline phosphatase in disease affecting the pancreas, hepatobiliary tree and bone. Amer. J. Med. 1961; 31: 231
   PubMedGoogle Scholar
• Hill P. G., Sammons H. G. An assessment of 5'-nucleotidase as a liver-function test. Quart. J. Med. 1967; 36: 457
   PubMedGoogle Scholar
• Bressler R., Forsyth B. R., Klatskin G. Serum leucine aminopeptidase activity in hepatobiliary and pancreatic disease. J. Lab. Clin. Med. 1960; 56: 417
   Google Scholar
• Wroblewski F. The clinical significance of transaminase activities of serum. Amer. J. Med. 1959; 27: 911
   PubMed Web of Science ®Google Scholar
• Dunn M., Martins J., Reissman K. R. The disappearance rate of glutamic oxaloacetic transaminase from the circulation and its distribution in the body's fluid compartment with secretions. J. Lab. Clin. Med. 1958; 51: 259
   PubMedGoogle Scholar
• Krugman S., Ward R. Infectious Diseases of Children, 2nd ed., C. V. Mosby, St Louis 1960
   Google Scholar
• Clermont R. J., Chalmers T. C. The transaminase tests in liver disease. Medicine 1967; 46: 197
   PubMed Web of Science ®Google Scholar
• Helman R. A., Temko M. H., Nye S. W., Fallon H. J. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann. Intern. Med. 1971; 74: 311
   PubMed Web of Science ®Google Scholar
• Zimmerman H. J., West M. Serum enzyme levels in the diagnosis of hepatic disease. Amer. J. Gastroenterol. 1963; 40: 387
   PubMedGoogle Scholar
• Walls W. D., Losowsky M. S. The hemostatic defect of liver disease. Gastroenterology 1971; 60: 108
   PubMedGoogle Scholar
• Ratnoff O. D. Disordered hemostasis in hepatic disease. Diseases of the Liver, 3rd ed., L. Schiff. J. B. Lippincott, Philadelphia 1969
   Google Scholar
• Quick A. J. Hemorrhagic Diseases and Thrombosis, 2nd ed. Lea and Febiger, Philadephia 1966; 391
   Google Scholar
• Schiff L., Gall F. A. Needle biopsy of the liver. Diseases of the Liver, 3rd ed., L. Schiff. J. B. Lippincott, Philadelphia 1969; 209
   Google Scholar
• Stein H. B. “Prothrombin response to vitamin K test” in differentiation between intra- and extrahepatic jaundice. S. Afr. J. Med. Sci. 1944; 9: 111
   Google Scholar
• Liebowitz H. R., Rousselot L. M. Bleeding Esophageal Varices: Portal Hypertension. Charles C Thomas, Springfield, Ill 1959
   Google Scholar
• Harinasuta U., Chomet B., Ishak K., Zimmerman H. J. Steatonecrosis-Mallory body type. Medicine 1967; 46: 141
   PubMed Web of Science ®Google Scholar
• Owen J. A., Robertson R. F. Paper electrophoresis of serum proteins in hepatobiliary disease. Lancet 1956; 2: 1125
   Google Scholar
• Owen J. A. Paper electrophoresis of proteins and protein-bound substances in clinical investigations. Advances in Clinical Chemistry, H. Sobotka, C. P. Stewart. Academic Press, New York 1958; Vol. 1: 237
   Google Scholar
• Sherlock S. Diseases of the Liver, 4th ed. F. A. Davis, Philadelphia 1968; 419
   Google Scholar
• Lee F. I. Immunoglobulins in viral hepatitis and active alcoholic liver disease. Lancet 1965; 2: 1043
   PubMed Web of Science ®Google Scholar
• Paronetto F., Schaffner F., Popper H. Immunocytochemical and serologic observations in primary biliary cirrhosis. New Eng. J. Med 1964; 271: 1123
   PubMed Web of Science ®Google Scholar
• Feizi T. Immunoglobulins in chronic liver disease. Gut 1968; 9: 193
   PubMed Web of Science ®Google Scholar
• Maclagan N. F., Martin N. H., Lunnon B. J. The mechanism and interrelationships of the flocculation tests. J. Clin Path. 1952; 5: 1
   PubMedGoogle Scholar
• Cohn E. M. Diagnostic procedures in the evaluation of hepatic disease. Gastroenterology, 2nd ed., H. L. Bockus. W. B. Saunders, Philadelphia 1965; Vol. III: 129
   Google Scholar
• Bouchier I. A. D. Clinical Investigation of Gastrointestinal Function, 1st ed. Blackwell, Oxford 1969; 205
   Google Scholar
• Kunkel H. G. Estimation of alterations of serum gamma globulin by a turbidimetric technique. Proc. Soc. Exp. Biol. Med. 1947; 66: 217
   PubMed Web of Science ®Google Scholar
• Gutman A. B., Hanger F. M. Differential diagnosis of jaundice: by combined serum phosphatase determinations and cephalin flocculation test. Med. Clin. N. Amer. 1941; 25: 837
   Google Scholar
• Kunkel H. G. Value and limitations of the thymol turbidity test as an index of liver disease. Amer. J. Med. 1948; 4: 201
   PubMed Web of Science ®Google Scholar
• Hill E., Zieve L. Discrimination between obstructive and hepatocellular jaundice by means of the commonly used serum tests. Amer. J. Clin Path. 1957; 27: 6
   PubMedGoogle Scholar
• Kater R. M. H., Mistilis S. P. Obstetric cholestasis and pruritus of pregnancy. Med J. Austr. 1967; 1: 638
   PubMedGoogle Scholar
• Adams R. H., Gordon J., Combes B. Hyperemesis gravidarum. I. Evidence of hepatic dysfunction. Obstet. Gynec. 1968; 31: 659
   PubMed Web of Science ®Google Scholar
• Adams R. H., Combes B. Viral hepatitis during pregnancy. J.A.M.A. 1965; 192: 195
   PubMed Web of Science ®Google Scholar
• Doniach D., Roitt I. M., Walker J. G., Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic hepatitis (lupoid hepatitis), cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin. Exp. Immun. 1966; 1: 237
   PubMedGoogle Scholar
• Walker J. G., Doniach D., Roitt I. M., Sherlock S. Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1965; 1: 827
   PubMed Web of Science ®Google Scholar
• Gajdusek D. C. An “autoimmune” reaction against human tissue antigens in certain acute and chronic diseases. Arch. Intern. Med. 1958; 101: 9
   Google Scholar
• Mackay I. R., Taft L. I., Cowling D. C. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet 1959; 1: 65
   PubMed Web of Science ®Google Scholar
• Paronetto F., Schaffner F., Popper H. Immunocytochemical reaction of serum of patients with hepatic diseases with hepatic structures. Proc. Soc. Exp. Biol. Med. 1961; 106: 216
   PubMedGoogle Scholar
• Weir D. M., Holborow E. J., Johnson G. D. A clinical study of serum antinuclear factor. Brit. Med. J. 1961; 1: 933
   PubMed Web of Science ®Google Scholar
• Johnson G. D., Holborow E. J., Glynn L. E. Antibody to smooth muscle in patients with liver disease. Lancet 1965; 2: 878
   PubMed Web of Science ®Google Scholar
• Berg P. A., Doniach D., Roitt I. M., Cooper H. M. Mitochondrial antibodies in primary biliary cirrhosis. Immunology 1969; 17: 281
   PubMedGoogle Scholar
• Rodriguez M., Paronetto F., Schaffner F., Popper H. Antimitochondrial antibodies in jaundice following drug administration. J.A.M.A. 1969; 208: 148
   PubMedGoogle Scholar
• Whaley K., Goudie R. B., Williamson J., Nuki G., Dick W. C., Buchanan W. W. Liver disease in Sjogren's syndrome and rheumatoid arthritis. Lancet 1970; 1: 861
   PubMed Web of Science ®Google Scholar
• Berg P. A., Doniach D., Roitt I. M. Immunologische Phanomene bei Leberkrankheiten: Dei Bedeutung mitochondrialer Antikorper. Klin. Wschr. 1969; 47: 1297
   PubMedGoogle Scholar
• Mistilis S. P. Pericholangitis and ulcerative colitis. Pathology, etiology and pathogenesis. Ann. Intern Med. 1965; 63: 1
   PubMed Web of Science ®Google Scholar
• Walker J. G., Doniach D., Doniach I. Mitochondrial antibodies and subclinical liver disease. Quart. J. Med. 1970; 39: 31
   PubMedGoogle Scholar
• Walker J. G., Doniach D., Roitt I. M., Sherlock S. Immune studies in liver disease. The Liver, A. E. Read. Colston Papers, London 1967; Vol. 19: 83
   Google Scholar
• Whittingham S., Irwin J., Mackay I. R., Smalley M. Smooth muscle auto antibody in “autoimmune” hepatitis. Gastroenterology 1966; 51: 499
   PubMed Web of Science ®Google Scholar
• Doniach D. The concept of an “Autoallergic” hepatitis. Proc. Roy. Soc. Med. 1970; 63: 527
   PubMedGoogle Scholar
• Doniach D., Walker J. G. A unified concept of autoimmune hepatitis. Lancet 1969; 1: 813
   PubMedGoogle Scholar
• Diederichsen H. Hetero-antibody against bile canaliculi in patients with chronic, clinically active hepatits. Acta Med Scand. 1969; 186: 299
   PubMedGoogle Scholar
• Goudie R. B., Macsween R. N. M., Goldberg D. M. Serological and histological diagnosis of primary biliary cirrhosis. J. Clin. Path. 1966; 19: 527
   PubMed Web of Science ®Google Scholar
• Kantor F. S., Klatskin G. Serological diagnosis of primary biliary cirrhosis: a potential clue to pathogenesis. Trans. Ass. Amer. Physicians 1967; 80: 267
   PubMedGoogle Scholar
• Whittingham S., Mackay I. R., Irwin J. Autoimmune hepatitis: immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet 1966; 1: 1333
   PubMed Web of Science ®Google Scholar
• Paronetto F., Schaffner F., Popper H. Antibodies to cytoplasmic antigens in primary biliary cirrhosis and chronic active hepatitis. J. Lab. Clin. Med 1967; 69: 979
   PubMed Web of Science ®Google Scholar
• Wright R. Australia antigen and smooth-muscle antibody in acute and chronic hepatitis. Lancet 1970; 1: 521
   PubMed Web of Science ®Google Scholar
• Bouchier I. A. D., Rhodes K., Sherlock S. Serological abnormalities in patients with liver disease. Brit. Med J. 1964; 1: 592
   PubMedGoogle Scholar
• Blumberg B. S., Alter H. J., Visnich S. A “new” antigen in leukemia sera. J.A.M.A. 1965; 191: 541
   PubMed Web of Science ®Google Scholar
• Blumberg B. S., Sutnick A. I., London W. T. Australia antigen as a hepatitis virus. Variation in host response. Amer. J. Med. 1970; 48: 1
   PubMed Web of Science ®Google Scholar
• Blumberg B. S., Sutnick A. I., London W. T., Millman I. Current concepts. Australia antigen and hepatitis. New Eng. J. Med. 1970; 283: 349
   PubMed Web of Science ®Google Scholar
• Shulman N. R., Hirschman R. J., Barker L. F. Viral hepatitis. Ann. Intern. Med. 1970; 72: 257
   PubMed Web of Science ®Google Scholar
• Chang L. W., O'Brien T. F. Australia antigen serology in the Holy Cross football team hepatitis outbreak. Lancet 1970; 2: 59
   Google Scholar
• Mosley J. W., Barker L. F., Shulman N. R., Hatch M. H. Failure to detect an antigen associated with hepatitis in a community epidemic. Nature 1970; 225: 953
   PubMed Web of Science ®Google Scholar
• Prince A. M., Hargrove R. L., Szmuness W., Cherubin C. E., Fontana V. J., Jeffries G. H. Immunologic distinction between infectious and serum hepatitis. New Eng. J. Med. 1970; 282: 987
   PubMed Web of Science ®Google Scholar
• Dane D. S., Cameron C. H., Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1970; 1: 695
   PubMed Web of Science ®Google Scholar
• Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc. Nat. Acad. Sci. USA 1968; 60: 814
   PubMed Web of Science ®Google Scholar
• Purcell R. H., Holland P. V., Walsh J. H., Wong D. C., Morrow A. G., Chanock R. M. A complement fixation test for measuring Australia antigen and antibody. J. Infect. Dis 1969; 120: 383
   PubMed Web of Science ®Google Scholar
• Shulman N. R., Barker L. F. Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science 1969; 165: 304
   PubMed Web of Science ®Google Scholar
• Gocke D. J., Howe C. Rapid detection of Australia antigen by counterimmunoelectrophoresis. J. Immun 1970; 104: 1031
   PubMed Web of Science ®Google Scholar
• Prince A. M., Burke K. Serum hepatitis antigen (S.H.): rapid detection by high voltage immunoelectrosmophoresis. Science 1970; 169: 593
   PubMed Web of Science ®Google Scholar
• Saravis C. A., Trey C., Grady G. F. Rapid screening test for detecting hepatitis-associated antigen. Science 1970; 169: 298
   PubMedGoogle Scholar
• Rightsel W. A., Moore H. A., Muirhead E. E. Electroprecipitin test for hepatitis-associated antigen and antibody. Amer. J. Clin. Path. 1971; 55: 249
   PubMedGoogle Scholar
• Vyas G. N., Shulman N. R. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science 1970; 170: 332
   PubMed Web of Science ®Google Scholar
• Walsh J. H., Yalo R., Berson S. A. Detection of Australia antigen by means of radioimmunoassay techniques. J. Infect. Dis. 1970; 121: 550
   PubMed Web of Science ®Google Scholar
• Kaplan M. M., Grady G. Serum-hepatitis antigen in chronic hepatitis and primary biliary cirrhosis. Lancet 1971; 1: 159
   PubMedGoogle Scholar
• Thulstrup H., Dybkjaer E. Screening for hepatitis associated antigen by three different methods. Vox Sang. 1970; 19: 234
   PubMedGoogle Scholar
• Okochi K., Mayumi M., Haguino Y., Saito N. Evaluation of Australia antigen in blood donors of Tokyo by means of immune adherence hemagglutination technique. Vox Sang. 1970; 19: 332
   PubMedGoogle Scholar
• Unpublished data presented by Dr. James Boyer at the Annual Meeting of American Gastroenterology Association, Miami, Florida, May, 1971
   Google Scholar
• Kapsenberg J. G., Langenhuysen M. M. A. C., Nieweg H. O., Deiss H. Post transfusion mononucleosis with heterophil antibodies. Acta Med. Scand. 1970; 187: 79
   PubMedGoogle Scholar
• Lang D. J., Scolnick E. M., Willerson J. T. Association of cytomegalovirus infection with the postperfusion syndrome. New Eng J. Med. 1968; 278: 1147
   PubMed Web of Science ®Google Scholar
• Okochi K., Murakami S. Observations on Australia antigen in Japanese. Vox Sang. 1968; 15: 374
   PubMed Web of Science ®Google Scholar
• Shulman N. R. Hepatitis associated antigen. Amer. J. Med. 1970; 49: 669
   PubMed Web of Science ®Google Scholar
• Wright R. The Australia antigen in chronic active hepatitis. Vox Sang. 1970; 19: 320
   PubMedGoogle Scholar
• Sutnick A. J., London W. T., Millman I., Coyne V. E., Blumberg B. S. Viral hepatitis. Revised concepts as a result of the study of Australia antigen. Med Clin N. Amer. 1970; 54: 805
   PubMed Web of Science ®Google Scholar
• Giles J. P., McCollum R. W., Berndtson L. W., Krugman S. Viral hepatitis. Relation of Australia/SH antigen to the Willowbrook MS-2 strain. New Eng. J. Med. 1969; 281: 119
   PubMed Web of Science ®Google Scholar
• Gitnick G. I., Gleich G. J., Schoenfield L. J., et al. Australia antigen in chronic active liver disease with cirrhosis. Lancet 1969; 2: 285
   PubMedGoogle Scholar
• Fox R. A., Niazi S. P., Sherlock S. Hepatitis associated antigen in chronic liver disease. Lancet 1969; 2: 609
   PubMedGoogle Scholar
• Bulkley B. H., Heizer W. D., Goldfinger S. E., Isselbacher K. J., Shulman N. R. Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet 1970; 2: 1323
   PubMed Web of Science ®Google Scholar
• Prince A. M., Leblanc L., Krohn K., Masseyeft R., Alpert M. E. S. H. antigen and chronic liver disease. Lancet 1970; 2: 717
   PubMedGoogle Scholar
• Matthews J. D., Mackay I. R. Australia antigen in chronic hepatitis in Australia. Brit. Med. J. 1970; 1: 259
   PubMedGoogle Scholar
• Singleton J. W., Fitch R. A., Merrell D., Rettberg W. A. H. Liver disease in hepatitis-associated-antigen (HAA) positive blood donors. Gastroenterology 1971; 60: 721
   Google Scholar
• Krohn K., Finlayson N. D. C., Jokelainen P. T., Andersen K. E., Prince A. M. Electron microscopical and immunological observations on the serum-hepatitis (S.H.) antigen in primary biliary cirrhosis. Lancet 1970; 2: 379
   PubMed Web of Science ®Google Scholar
• Wright R., McCollum R. W., Klatskin G. Australia antigen in acute and chronic liver disease. Lancet 1969; 2: 117
   PubMed Web of Science ®Google Scholar
• Denison E. K., Peter R. L., Reynolds T. B. Familial hepatoma with hepatitis-associated antigen. Ann Intern Med. 1971; 74: 391
   PubMed Web of Science ®Google Scholar
• Sherlock S., Fox R. A., Niazi S. P., Scheuer P. J. Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen. Lancet 1970; 1: 1243
   PubMed Web of Science ®Google Scholar
• Alter H. J., Holland P. V., Schmidt P. J. Hepatitis-associated antigen. To test or not to test?. Lancet 1970; 2: 142
   PubMedGoogle Scholar
• Taswell H. F., Shorter R., Poncelet T. K., Maxwell N. G. Hepatitis associated antigen in blood donor populations. J.A.M.A. 1970; 214: 142
   PubMedGoogle Scholar
• Cherubin C. E., Prince A. M. Serum hepatitis specific antigen (SH) in commercial and volunteer sources of blood. Transfusion 1971; 11: 25
   PubMedGoogle Scholar
• Grindon A. J., Holland P. V., Schmidt P. J. Posttransfusion hepatitis. Amer. Heart J. 1967; 74: 591
   PubMedGoogle Scholar
• Leski M., Grivaux C., Courouce-Pauty A. M. Australia antigen in hemodialysis and renal transplantation units. Vox Sang. 1970; 19: 359
   PubMedGoogle Scholar
• Turner G. C., Bruce White G. B. SH antigen in hemodialysis associated hepatitis. Lancet 1969; 2: 121
   PubMed Web of Science ®Google Scholar
• London W. T., Blumberg B. S. Hepatitis in hemodialysis unit. Australia antigen and host's response. New Eng. J. Med. 1969; 281: 571
   PubMed Web of Science ®Google Scholar
• Ringertz O., Nystrom B. Hepatitis in a hemodialysis unit. Lancet 1969; 2: 745
   PubMedGoogle Scholar
• Hawe B. J., Goldsmith H. J., Jones P. O. Dialysis-associated hepatitis: Prevention and control. Brit. Med. J. 1971; 1: 540
   PubMedGoogle Scholar
• Blainey J. D., Earle A., Flewett T. H., Williams L. K. L. Is the urine infective in serum hepatitis?. Lancet 1971; 1: 797
   PubMed Web of Science ®Google Scholar
• Grob P. J., Jemelka H. Faecal SH (Australia) antigen in acute hepatitis. Lancet 1971; 1: 206
   PubMed Web of Science ®Google Scholar
• Gust I. D., Kaldor J., Nastasi M. Absence of Au antigen in faeces of patients with Au-positive sera. Lancet 1971; 1: 797
   PubMed Web of Science ®Google Scholar
• Willems Th. F. C., Kunst V. A. J. M., Rosier J. G. M. C. Complement-fixation test for Australia antigen. Lancet 1970; 1: 953
   PubMedGoogle Scholar
• Cossart Y. E., Vahrman J. Studies of Australia-SH antigen in sporadic viral hepatitis in London. Brit. Med. J. 1970; 1: 403
   PubMedGoogle Scholar
• Barker L. F., Peterson M. R., Murray R. Application of the microtiter complement fixation technique to studies of hepatitis associated antigen in human hepatitis. Vox Sang. 1970; 19: 211
   PubMedGoogle Scholar
• Walsh J. H., Yalow R. S., Berson S. A. Radioimmunoassay of Australia antigen. Vox Sang. 1970; 19: 217
   PubMedGoogle Scholar
• Hansson B. G., Kindmark C. O., Johnson T. Comparison between the immunoelectroosmophoresis and the Ouchterlony precipitation technique in detecting Australia antigen in cases of hepatitis. Vox Sang. 1970; 19: 225
   PubMedGoogle Scholar
• Prince A. M. The high voltage immunoelectroosmophoretic (IEOP) technique for detection of SH antigen: Application to blood donor screening and to study of liver disease. Vox Sang. 1970; 19: 205
   PubMedGoogle Scholar
• Gocke D. J. The Australia antigen and blood transfusion. Vox Sang. 1970; 19: 327
   PubMedGoogle Scholar
• Terrier E., Simonneau M., Jaulines B. Screening blood donors for Australia antigen carriers at the Broussais Hospital. Vox Sang. 1970; 19: 352
   PubMedGoogle Scholar
• Githin D., Boesman M. Serum α-fetoprotein, albumin, and γG globulin in the human conceptus. J. Clin. Invest. 1966; 45: 1826
   PubMedGoogle Scholar
• Foy H., Kondi A., Parker A. M., Stanley R., Venning C. D. The α-fetoprotein test in pregnant women, women on oral contraceptives, newborn babies, and pyridoxine-deprived baboons. Lancet 1970; 760: 1336
   PubMedGoogle Scholar
• Uriel J., et al. Antigenes embryonnaires et cancer du foie chez I'homme: association de I'alpha-I-fetoproteine serique avec I'hepatome primaire. Compt. Rend. Acad. Sci 1967; 265: 75
   Google Scholar
• Smith J. B. Alpha-fetoprotein: Occurrence in certain malignant diseases and review of clinical applications. Med. Clin N. Amer. 1970; 54: 797
   PubMedGoogle Scholar
• Tatarinov T. S. Content of embryo-specific α-globulin in fetal and neonatal sera and sera from adult humans with primary carcinoma of the liver. Fed Proc. Transl. Suppl., pt. 2 1966; 25: T-344
   PubMedGoogle Scholar
• Abelev G. I., Assecritova I. V., Kraevsky N. A., Perova S. D., Perevodchikova N. I. Embryonal serum α-globulin in cancer patients: Diagnostic value. Int. J. Cancer 1967; 2: 551
   PubMed Web of Science ®Google Scholar
• Marwas C., Buffe D., Burtin P. Influence of age on α-fetoprotein incidence. Lancet 1970; 1: 1292
   Google Scholar
• Masepust J., Kithier K., Radl J., Kontecky J., Kotal L. Occurrence of fetoprotein in patients with neoplasms and non-neoplastic diseases. Int. J. Cancer 1968; 3: 364
   PubMedGoogle Scholar
• Alpert M. E., Seeler R. A. Alpha fetoprotein in embryonal hepatoblastoma. J. Pediat. 1970; 77: 1058
   PubMedGoogle Scholar
• Alpert M. E., Uriel J., DeNechaud B. Alpha 1 fetoglobulin in the diagnosis of human hepatoma. New Eng. J. Med 1968; 278: 984
   PubMed Web of Science ®Google Scholar
• Geffroy Y., Denis P., Colin R., Sauger Matray F., Fondimare A. Presence of alpha fetoprotein in an adult with viral hepatitis treated with corticosteroids. Presse Med. 1970; 78: 1107
   Google Scholar
• Alpert M. E. α-1-fetoprotein in human hepatoma. Clin. Res 1969; 17: 461
   Google Scholar
• Purves L R., MacNab M., Geddes E. W., Bersohn I. Serum-α-fetoprotein and primary hepatic cancer. Lancet 1968; 1: 921
   PubMedGoogle Scholar
• Purves L. R., MacNab M., Bersohn I. Fetoglobulin and primary liver cancer. Lancet 1968; 2: 634
   Web of Science ®Google Scholar
• Foli A. K., Sherlock S., Adinolphi M. Serum α1-fetoprotein in patients with liver disease. Lancet 1969; 2: 1267
   Web of Science ®Google Scholar
• Foy H., Kondi A., Linsell C. A., Parker A. M., Sizaret P. The α1-fetoprotein test in hepatocellular carcinoma. Lancet 1970; 1: 441
   Google Scholar
• Gold P., Freedman S. O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunologic tolerance and absorption techniques. J. Exp. Med. 1965; 121: 439
   PubMed Web of Science ®Google Scholar
• Tatarinov J. S., Nogaller A. M. Diagnostic importance of the embryo-specific α-globulin detection in the blood serum of hepatoma patients. Vop. Onkol 1966; 12: 10
   Google Scholar
• Smith J. B., Todd D. Fetoglobin and primary liver cancer. Lancet 1968; 2: 833
   PubMed Web of Science ®Google Scholar
• Geddes E. W., Falkson G. F. Malignant hepatoma in the Bantu. Cancer 1970; 25: 1271
   PubMedGoogle Scholar
• Economopoulos P., Theodoropoulos G., Sakellaropoulos N. α-fetoprotein in Greece and France. Lancet 1970; 1: 1337
   Google Scholar
• Hull E. W., Carbone P. P., Moertel C. G., O'Connor G. T. Serum α-fetoprotein in the USA. Lancet 1970; 1: 779
   Google Scholar
• Cook G. C., Mulligan R., Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quart. J. Med 1971; 40: 159
   PubMedGoogle Scholar